← All trials
NCT06281756
Early Phase 1Interventional
Exploratory trials, involving very limited human exposure, with no therapeutic or diagnostic intent (e.g., screening studies, microdose studies).
View on ClinicalTrials.gov ↗Timeline
- Start date
- Mar 14, 2024
- Primary completion
- Feb 28, 2027
- Completion date
- Feb 29, 2028
- First posted
- Feb 28, 2024
- Last posted
- Sep 19, 2024
- Enrollment
- 600
- Arms / groups
- 2 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Pennsylvania State UniversityLead sponsor
- National Heart, Lung, and Blood Institute (NHLBI)Collaborator
- Pennsylvania State UniversitySponsor investigator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.